These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 10692752

  • 1. A dose-defining study of sumatriptan suppositories in the acute treatment of migraine.
    Bertin L, Brion N, Färkkilä M, Göbel H, Wessely P.
    Int J Clin Pract; 1999 Dec; 53(8):593-8. PubMed ID: 10692752
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sumatriptan suppositories for the acute treatment of migraine. S2B351 Study Group.
    Tepper SJ, Cochran A, Hobbs S, Woessner M.
    Int J Clin Pract; 1998 Dec; 52(1):31-5. PubMed ID: 9536565
    [Abstract] [Full Text] [Related]

  • 4. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
    Winner P, Rothner AD, Wooten JD, Webster C, Ames M.
    Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group.
    Savani N, Brautaset NJ, Reunanen M, Szirmai I, Ashford EA, Hassani H, Saiers J.
    Int J Clin Pract Suppl; 1999 Aug; 105():7-15. PubMed ID: 10692717
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths.
    Cutler N, Mushet GR, Davis R, Clements B, Whitcher L.
    Neurology; 1995 Aug; 45(8 Suppl 7):S5-9. PubMed ID: 7644082
    [Abstract] [Full Text] [Related]

  • 9. Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group.
    Salonen R, Ashford EA, Gibbs M, Hassani H.
    Int J Clin Pract Suppl; 1999 Aug; 105():16-24. PubMed ID: 10692718
    [Abstract] [Full Text] [Related]

  • 10. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ.
    Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC.
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ, Massiou H, Lainez JM, Cabarrocas X.
    Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G, Blumenthal H, Webster CJ, Richardson MS, Ames M.
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of sumatriptan injection for the treatment of morning migraine: two multicenter, prospective, randomized, double-blind, controlled studies in adults.
    Winner P, Adelman J, Aurora S, Lener ME, Ames M.
    Clin Ther; 2006 Oct; 28(10):1582-91. PubMed ID: 17157114
    [Abstract] [Full Text] [Related]

  • 19. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J, Cady R, Singer R, Peters K, Webster C, Kori S, Byrd S.
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [Abstract] [Full Text] [Related]

  • 20. Patient-selected dosing in a six-month open-label study evaluating oral sumatriptan in the acute treatment of migraine. Sumatriptan Tablets S2CM10 Study Group.
    Dowson AJ, Ashford EA, Prendergast S, Hassani H, Roberts GW, Flöter T, Szczudlik A.
    Int J Clin Pract Suppl; 1999 Aug; 105():25-33. PubMed ID: 10692719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.